Does treadmill-based gait training with the Incedo-system improve walking performance and gait parameters in subacute stroke patients with severe hemiparesis who are unable to walk independently

Organizational Data

DRKS-ID:
DRKS00031910
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2023-06-15
Last update in DRKS:
2024-04-05
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Improving walking ability is an important goal in the neurological rehabilitation of stroke patients. Increasingly, gait training is carried out in combination with electrical stimulation of the lower extremity. The aim of this study is to test the effect of treadmill-based gait training in combination with electrostimulation using the Incedo system on subacute patients who are unable to walk independently after a stroke. The study is intended to improve therapy options for patients with stroke. The electrostimulation is carried out with the Incedo system. Stimulation of the foot sole activates the so-called flexor reflex, which triggers a reflexive flexion in the leg. The test persons are divided into either the intervention group or the control group. For the classification, the general walking ability on the floor and the walking performance on the treadmill with and without electrical stimulation on the foot sole are first recorded. The study consists of a pre- and post-test and a 6-week training period. In the pre- and post-tests, somatosensory testing, muscle function testing, spasticity testing, general walking ability testing, the 2-minute walking test on the treadmill and measurement of sensory evoked potentials (SEP's) from the tibial nerve will be performed. The testing of the muscle strength of the affected leg as well as the testing of the general walking ability on the floor and the walking performance on the treadmill are filmed. At all three test points, the BORG scale is used to determine how demanding walking on the treadmill is for the patient. In addition, a questionnaire is used to test how physically demanding it is for the physiotherapist to support the patient while walking on the treadmill. During the 6-week training period, the patients in the intervention group receive 30 minutes of gait training twice a week on the treadmill with combined electrostimulation (Incedo-system) of the affected leg. The patients in the control group receive the same amount of training without electrostimulation of the affected leg. Each patient will complete a total of 12 training sessions. Six weeks after the training, if possible, the same tests as before the training and immediately afterwards are carried out. The gait training takes place within the regular physiotherapy sessions. It is not an add-on intervention.

Brief summary in scientific language

Improving walking ability is an important goal in the neurological rehabilitation of stroke patients. Increasingly, gait training is carried out in combination with electrical stimulation of the lower extremity. The study examines whether treadmill-based gait training in combination with the Incedo-system can improve walking performance and gait parameters in subacute non-ambulatory patients with severe stroke-related hemiparesis? Subacute stroke patients who are unable to walk independently will be recruited and assigned to either the intervention or the control group according to the case-control principle. The results in the Functional Ambulations Categoris (0 - 1) and the results in the 2-minute walking test on the treadmill will be used as criteria for allocation to the groups. There is a baseline-test before the start of the training and a post-test directly after the six weeks of training. A follow-up test is conducted after a further six weeks. The following parameters are recorded at each test time: - Modified muscle function test - Somatosensory test - Measurement of spasticity (Tardieu-Scale) - Assessment of walking ability (Functional Ambulation Categories) - Two-minute walking test on the treadmill (with and without Incedo- system). With recording of: a) Amount of weight relief b) Distance covered c) Number of steps d) Degree of exertion for patients (BORG scale) e) Degree of effort for therapists (questionnaire) - Video recordings of the muscle strength of the affected leg as well as the patient's gait pattern on the floor and the treadmill. - Sensory evoked potentials (SEP) of N. tibialis During the 6-week training period, the patients in the intervention group receive 30 minutes of gait training twice a week on the treadmill with combined electrostimulation (Incedo-system) of the affected leg. The patients in the control group receive the same amount of training, but without electrostimulation of the affected leg. In total, each patient should complete 12 training units. The gait training takes place within the regular physiotherapy sessions. It is not an add-on intervention.

Health condition or problem studied

ICD10:
I60 - Subarachnoid haemorrhage
ICD10:
I61 - Intracerebral haemorrhage
ICD10:
I62 - Other nontraumatic intracranial haemorrhage
ICD10:
I63 - Cerebral infarction
ICD10:
I64 - Stroke, not specified as haemorrhage or infarction
Healthy volunteers:
No

Interventions, Observational Groups

Arm 1:
Intervention group: Gait training on the treadmill, under weight relief with the Incedo-system, 2x per week, 30 minutes for 6 weeks.
Arm 2:
Control group: Gait training on the treadmill, under weight relief, 2x per week, 30 minutes for 6 weeks. Wearing a foot lift orthosis is allowed during training.

Endpoints

Primary outcome:
The aim of the study is to determine whether treadmill-based gait training in combination with electrical stimulation of the foot sole, with the Incedo-system, leads to an improvement in the walking performance and gait parameters of patients after stroke who are unable to walk independently. There is a baseline-test before the start of the training and a post-test directly after the six weeks of training. A follow-up test is conducted after a further six weeks. The following parameters are recorded at each test time: - Modified muscle function test - Somatosensory test - Measurement of spasticity (Tardieu-Scale) - Assessment of walking ability (Functional Ambulation Categories) - Two-minute walking test on the treadmill (with and without Incedo-system). With recording of: a) Amount of weight relief b) Distance covered c) Number of steps d) Degree of exertion for patients (BORG scale) e) Degree of effort for therapists (questionnaire) - Video recordings of the muscle strength of the affected leg as well as the patient's gait pattern on the floor and the treadmill. - Sensory evoked potentials (SEP) of N. tibialis
Secondary outcome:
None

Study Design

Purpose:
Treatment
Allocation:
Non-randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Crossover
Sequence generation:
No Entry
Who is blinded:
  • Investigator/therapist

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Lurija Institut, Kliniken Schmieder Allensbach Allensbach

Recruitment period and number of participants

Planned study start date:
2024-04-05
Actual study start date:
2024-04-05
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
50
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
Female
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
- Stroke < 6 months - Patients who can only walk with the permanent support of at least one assistant (FAC 0-1) - Patients with whom treadmill-assisted gait training can be carried out with weight support - Patients are trunk stable (item sitting from the Trunk Control Test = 25 points) - Patient is able to tolerate electrostimulation. - Visible response to stimulation both sitting and walking - Ability to give consent to participate in the study and to follow instructions - Ability to communicate - Electrostimulation is only used with the consent of the doctor treating the patient

Exclusion Criteria

- More than one stroke in the history, unless the patient has no neurological deficits from the previous strokes. - Other neurological diseases - Lack of compliance - Epilepsy - Patients with heart pacemakers - Patients with severe heart or lung diseases - Patients with cancer - Skin lesions in the area where the electrode is positioned - Pregnancy - Patients who adjust to the electrical stimulus in a short time or patients in whom a higher stimulation intensity triggers spasticity or clonus in the affected leg

Addresses

Primary Sponsor

Address:
Lurija Institut, Kliniken Schmieder
Zum Tafelholz 8
78476 Allensbach
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Lurija Institut, Kliniken Schmieder
Prof. Dr. Joachim Liepert
Zum Tafelholz 8
78476 Allensbach
Germany
Telephone:
07533 808 1212
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Lurija Institut, Kliniken Schmieder Allensbach
B.Sc. Jana Stürner
Zum Tafelholz 8
78476 Allensbach
Germany
Telephone:
07533 808 1404
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Lurija Institut, Kliniken Schmieder
Prof. Dr. Joachim Liepert
Zum Tafelholz 8
78476 Allensbach
Germany
Telephone:
07533 808 1212
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Private sponsorship (foundations, study societies, etc.)

Address:
Lurija Institut
78476 Allensbach
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Universität Konstanz
Universitätsstraße 10
78464 Konstanz
Germany
Telephone:
Keine Angaben
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2023-04-02
Ethics committee number:
14-2023
Vote of the Ethics Committee:
Approved
Date of the vote:
2023-04-17

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry